Publication | Closed Access

Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms

Dexmedetomidine-mediated ProtectionImmune RegulationImmunologyInnate ImmunityImmune SystemInflammationSepsisHepatotoxicityLiver PhysiologyChronic InflammationImmune FunctionPharmacologyInflammatory DiseaseDrug-induced Liver InjuryAnti-inflammatoryHepatologySeptic Liver InjuryCholinergic Anti-inflammatory MechanismsMedicine